WallStreetZenWallStreetZen

NASDAQ: SCLX
Scilex Holding Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SCLX stock forecasts and price targets.

Forecast return on equity

Is SCLX forecast to generate an efficient return?

Company
-27.1%
Industry
-2,018.09%
Market
142.96%
SCLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SCLX forecast to generate an efficient return on assets?

Company
80.56%
Industry
22%
SCLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SCLX earnings per share forecast

What is SCLX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$3.93
Avg 2 year Forecast
$3.17
Avg 3 year Forecast
$6.66

SCLX revenue forecast

What is SCLX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$107.1M+142.11%
Avg 2 year Forecast
$325.5M+635.89%
Avg 3 year Forecast
$523.9M+1,084.26%
SCLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCLX revenue growth forecast

How is SCLX forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
127.94%
Industry
5.77%
Market
24.86%
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCLX vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
SCLX$16.50N/AN/A
MDCX$2.44$23.50+863.11%Strong Buy
MIRA$1.67N/AN/A
AMRN$16.29$12.00-26.34%Strong Sell
OGN$6.75$14.00+107.41%Buy
View Top General Drug Manufacturer Stocks

Scilex Holding Co Stock Forecast FAQ

What is SCLX's earnings growth forecast for 2025-2027?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 30.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.

Scilex Holding Co's earnings in 2025 is -$122,989,000.On average, 3 Wall Street analysts forecast SCLX's earnings for 2025 to be -$27,315,022, with the lowest SCLX earnings forecast at -$26,243,845, and the highest SCLX earnings forecast at -$28,118,405. On average, 3 Wall Street analysts forecast SCLX's earnings for 2026 to be $22,064,862, with the lowest SCLX earnings forecast at $21,199,573, and the highest SCLX earnings forecast at $22,713,829.

In 2027, SCLX is forecast to generate $46,329,115 in earnings, with the lowest earnings forecast at $44,512,287 and the highest earnings forecast at $47,691,736.

If you're new to stock investing, here's how to buy Scilex Holding Co stock.

What is SCLX's revenue growth forecast for 2025-2027?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 127.94% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 24.86%.

Scilex Holding Co's revenue in 2025 is $44,236,000.On average, 3 Wall Street analysts forecast SCLX's revenue for 2025 to be $744,955,149, with the lowest SCLX revenue forecast at $715,741,221, and the highest SCLX revenue forecast at $766,865,594. On average, 3 Wall Street analysts forecast SCLX's revenue for 2026 to be $2,264,288,044, with the lowest SCLX revenue forecast at $2,175,533,351, and the highest SCLX revenue forecast at $2,330,923,622.

In 2027, SCLX is forecast to generate $3,643,880,987 in revenue, with the lowest revenue forecast at $3,500,941,414 and the highest revenue forecast at $3,750,998,721.

What is SCLX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SCLX) forecast ROA is 80.56%, which is higher than the forecast US Drug Manufacturers - General industry average of 22%.

What is SCLX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SCLX) Scilex Holding Co's current Earnings Per Share (EPS) is -$10.73. On average, analysts forecast that SCLX's EPS will be -$3.93 for 2025, with the lowest EPS forecast at -$3.77, and the highest EPS forecast at -$4.04. On average, analysts forecast that SCLX's EPS will be $3.17 for 2026, with the lowest EPS forecast at $3.05, and the highest EPS forecast at $3.27. In 2027, SCLX's EPS is forecast to hit $6.66 (min: $6.40, max: $6.86).

What is SCLX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SCLX) forecast ROE is -27.1%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.